Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Clinical Cardiology
Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE – BioSpace
Posted: Published on September 30th, 2019
Sept. 27, 2019 18:30 UTC Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients and vulnerable plaques that are at significantly higher risk for subsequent major adverse cardiovascular events BEDFORD, Mass.--(BUSINESS WIRE)-- Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced that the Lipid-Rich Plaque (LRP) Study was published online today in The Lancet. The landmark study demonstrated that near-infrared spectroscopy (NIRS) imaging of non-obstructive areas in patients undergoing cardiac catheterization and possible percutaneous coronary intervention (PCI) was safe and can aid in identifying patients and artery segments at higher risk for subsequent non-culprit major adverse cardiovascular events (NC-MACE). Continue reading
Posted in Clinical Cardiology
Comments Off on Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE – BioSpace
Off Script: The New Gatekeepers of Procedural Education – TCTMD
Posted: Published on September 30th, 2019
SAN FRANCISCO, CA I spent my second day at TCT 2019 sampling the excellent selection of practical educational opportunities in the TCT Training Pavilion and speaking to some of the professional staff supporting industry-led training programs. The last few years have seen a proliferation in the popularity of teaching pavilions at interventional cardiology conferences in which small group skill training is taught by experienced interventionalists, usually with the use of sophisticated procedural simulators. I found myself wondering: what has led to their rise in popularity, why are they found primarily at major meetings, and do they fulfill an important need Continue reading
Posted in Clinical Cardiology
Comments Off on Off Script: The New Gatekeepers of Procedural Education – TCTMD
Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy…
Posted: Published on September 30th, 2019
SAN FRANCISCO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc Continue reading
Posted in Clinical Cardiology
Comments Off on Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy…
TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 – TCTMD
Posted: Published on September 30th, 2019
SAN FRANCISCO, CAAmong patients with severe aortic stenosis at low surgical risk, TAVR is associated with improved disease-specific health status over SAVR at not only 1 month but also 6 and 12 months, according to a PARTNER 3 substudy. Despite the fact that patients werent overly symptomatic at baseline, these patients still saw a large improvement in quality of life, Suzanne J. Continue reading
Posted in Clinical Cardiology
Comments Off on TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 – TCTMD
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival – Diagnostic and Interventional Cardiology
Posted: Published on September 30th, 2019
September 25, 2019 Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting stents in randomized patients with de novo three-vessel and left main coronary artery disease, according to new research. The late-breaking results from the SYNTAX Extended Survival study were presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2019, Aug. Continue reading
Posted in Clinical Cardiology
Comments Off on Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival – Diagnostic and Interventional Cardiology
Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis – TCTMD
Posted: Published on September 30th, 2019
SAN FRANCISCO, CAIn patients with severe, symptomatic tricuspid regurgitation (TR), a comparison pitting a range of different transcatheter interventions against medical therapy suggests that the these approaches are associated with a lower risk of death and hospitalization for heart failure, as well as a lower risk of all-cause mortality. The new propensity-matched analysis, which was presented at TCT 2019 and published simultaneously in the Journal of the American College of Cardiology, suggests that the rate of survival free from heart failure at 1 year was 51.3% among patients treated with medical therapy and 68.4% among those treated with a transcatheter option (P = 0.0003). The analysis drew on registry numbers that included outcomes for several devices currently being used for tricuspid disease under compassionate use Continue reading
Posted in Clinical Cardiology
Comments Off on Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis – TCTMD
TCT 2019 Day Two: Transcatheter Valves, New and Old – TCTMD
Posted: Published on September 30th, 2019
SAN FRANCISCO, CASCOPE I is the first of two head-to-head trials underway for the investigational Acurate Neo transcatheter device (Boston Scientific), this one a comparison against Sapien 3 (Edwards Lifesciences). In the first surprise of the morning, this trial failed to meet its primary endpoint of noninferiority at 30 days and, indeed, in additional analyses, the Sapien 3 valve was shown to be superior, at least a for the composite endpoint of safety and efficacy used in this study. That included all-cause death, any stroke, life-threatening or disabling bleeding, major vascular complications, coronary artery obstruction requiring intervention, acute kidney injury stage 2 or higher, valve-related dysfunction requiring repeat procedure, rehospitalization for valve-related symptoms or congestive heart failure, moderate or severe prosthetic valve regurgitation or prosthetic valve stenosis at 30 days. Continue reading
Posted in Clinical Cardiology
Comments Off on TCT 2019 Day Two: Transcatheter Valves, New and Old – TCTMD
Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy – Health Imaging
Posted: Published on September 21st, 2019
As Duval points out, the cardiologists needed training in the advanced functionalities such as echo strain analysis and the 3D analysis embedded in the application. They needed image viewing to be closely integrated with the Epic EMR Continue reading
Posted in Clinical Cardiology
Comments Off on Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy – Health Imaging
A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred – Medscape
Posted: Published on September 21st, 2019
PHILADELPHIA Once again, the antidiabetic drug dapagliflozin (Farxiga, AstraZeneca) showed that the term "antidiabetic drug" doesn't really capture all that it might offer. In the randomized DEFINE-HF trial of patients with heart failure with reduced ejection fraction (HFrEF), either with or without type 2 diabetes, those who took dapagliflozin along with their standard heart failure meds rapidly showed fewer symptoms and improved quality of life Continue reading
Posted in Clinical Cardiology
Comments Off on A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred – Medscape
FDA Approves Novo Nordisk’s Oral Semaglutide, First GLP-1 in Pill Form – AJMC.com Managed Markets Network
Posted: Published on September 21st, 2019
Novo Nordisk officials believe the new therapy will fufill an unmet need for patients with type 2 diabetes and obesity who need a GLP-1 receptor agonist but do not wish to use an injectable drug. The filings are based on thePIONEER clinical trial programfor oral semaglutide, which included a cardiovascular outcomes trial Continue reading
Posted in Clinical Cardiology
Comments Off on FDA Approves Novo Nordisk’s Oral Semaglutide, First GLP-1 in Pill Form – AJMC.com Managed Markets Network